Immunovant (IMVT) insider trading in the last 6 months
Form 4 filings, newest first
6 insiders sold $12.5M. No buys.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Who files at Immunovant
Questions about IMVT's insider trades
Are IMVT insiders buying or selling?
6 insiders sold $12.5M across 33 filings in the last 6 months. No open-market buys on record. The newest filing: Tiago Girao, Chief Financial Officer, sold $188K on Oct 28, 2026.
Who are IMVT's biggest insider sellers?
By the dollars of their sales in the last 6 months: Andrew J. Fromkin (Director), 2 sales; Jay S. Stout (Chief Technology Officer), 10 sales; Melanie Gloria (Chief Operating Officer), 9 sales. 6 insiders sold in all.
When did an IMVT insider last buy?
No IMVT insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Tiago Girao on Oct 28, 2026.
Immunovant's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.